Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Craig Smucker

Adult Reconstructive Orthopaedic Surgery Wilmington, DE Medical Doctor

NPI 1497973754 CMS profile 159156

5317 Limestone Rd Ste 4, Wilmington, DE 19808

Open in the dashboard

General payments

$3,805

64 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Craig Smucker of Wilmington, DE is reported in the CMS Open Payments database as having received $3,805 across 64 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 29th percentile of Adult Reconstructive Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $887 16
2024 General $1,157 15
2023 General $665 10
2022 General $546 11
2021 General $439 8
2020 General $49 1
2019 General $62 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Craig Smucker
  • Adult Reconstructive Orthopaedic Surgery median
  • Middle half of Adult Reconstructive Orthopaedic Surgery
  • National median

In program year 2025, general payments to Craig Smucker were reported at $887. Among 1,079 Adult Reconstructive Orthopaedic Surgery profiles paid that year, the median was $1,406 and the middle half received between $318 and $8,709.

Show as a table
Year Craig Smucker Adult Reconstructive Orthopaedic Surgery median Middle half National median
2019 $62 $1,416 $292–$9,336 $163
2020 $49 $647 $141–$6,474 $114
2021 $439 $1,073 $211–$6,497 $132
2022 $546 $1,217 $236–$6,299 $149
2023 $665 $1,082 $246–$6,818 $160
2024 $1,157 $1,575 $323–$8,944 $164
2025 $887 $1,406 $318–$8,709 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Smith+Nephew, Inc. $1,005 12 payments
  2. Zimmer Biomet Holdings, Inc. $958 13 payments
  3. Stryker Corporation $638 16 payments
  4. Curonix LLC $231 2 payments
  5. Davol Inc. $203 2 payments
  6. Conformis, Inc. $169 2 payments
  7. Episurf Medical, Inc. $139 1 payment
  8. Ortho Development Corporation $138 2 payments
  9. Arthrex, Inc. $56 1 payment
  10. Wright Medical Technology, Inc. $49 1 payment
  11. Other $219 12 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,805 64 payments
Products named General payments · program years 2019–2025
  1. Persona $431 5 payments
  2. REAL INTELLIGENCE $344 4 payments
  3. REDAPT $319 4 payments
  4. PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A $231 2 payments
  5. MAKO Joint Replacement Hips, Knees $216 5 payments
  6. LEGION Revision $205 2 payments
  7. MAKO Knees, Hips $173 5 payments
  8. mymobility Platform $168 2 payments
  9. ANTHOLOGY $161 2 payments
  10. JOURNEY II $143 1 payment
  11. Other $2,086 47 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 10 drugs

Part D claims

336

Median for Orthopedic Surgery: 203

Drug cost

$3,069

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 98 $1,006
Celecoxib Generic 12 $804
Oxycodone Hcl Generic 69 $419
Naproxen Generic 25 $209
Amoxicillin Generic 50 $163
Ibuprofen Generic 19 $141
Doxycycline Hyclate Generic 11 $126
Mupirocin Generic 15 $83
Clindamycin Hcl Generic 17 $69
Meloxicam Generic 20 $49

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 94 billing codes

Paid by Medicare

$238,253

Of which drugs: $24,228

Medicare patients

626

Average age 74

Services billed

6,202

381 women, 245 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 30%
Ischemic heart disease 28%
Depression 28%
Chronic kidney disease 21%
Osteoporosis 19%
Atrial fibrillation 17%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg J7329 Office 22 2,725 $15,319
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 190 1,001 $739

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

64 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Adult Reconstructive Orthopaedic Surgery in Delaware

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record